US Patent Issued to The Board of Trustees of the Leland Stanford Junior University, The Children's Hospital of Philadelphia, The United States of America, as represented by the Secretary, Department of Health and Human Services on May 19 for "Chimeric antigen receptors targeting glypican-2" (California, Maryland, Pennsylvania Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,646, issued on May 19, was assigned to The Board of Trustees of the Leland Stanford Junior University (Palo Alto, Calif.), The Children's Hospital of Philadelphia (Philadelphia) and The United States of America, as represented by the Secretary, Department of Health and Human Services (Bethesda, Md.).

"Chimeric antigen receptors targeting glypican-2" was invented by Sabine Heitzeneder (Redwood City, Calif.), Robbie G. Majzner (Palo Alto, Calif.), Crystal L. Mackall (Stanford, Calif.), John M. Maris (Philadelphia), Kristopher R. Bosse (Philadelphia), Dimiter S. Dimitrov (Pittsburg, Pa.) and Zhongyu Zhu (Frederick, Md.).

According to the abstract* released by the U.S. Patent & Tradem...